Lactobacillus acidophilus Suppresses Colitis-Associated Activation of the IL-23/Th17 Axis
- 2015
- Journal of Immunology Research 2015
- PubMed: 25973440
- DOI: 10.1155/2015/909514
Study Design
- Type
- Clinical Trial
- Population
- DSS-induced mouse models of UC
- Methods
- In vivo experiment with mouse models.
- Highly Cited
- Animal Study
Abstract
The aim of this paper is to determine the modulatory effects of Lactobacillus acidophilus on the IL-23/Th17 immune axis in experimental colitis. DSS-induced mouse models of UC were to be saline, hormones, and different concentrations of Lactobacillus acidophilus intervention. The expression of interleukin- (IL-) 17, tumor necrosis factor α (TNFα), IL-23, transforming growth factor β1 (TGFβ1), signal transducer and activator of transcription 3 (STAT3), and phosphorylated (p)-STAT3 was examined by RT-PCR, Western blotting, and immunohistochemical analysis. And the results showed that administration of L. acidophilus suppressed Th17 cell-mediated secretion of proinflammatory cytokine IL-17 through downregulation of IL-23 and TGFβ1 expression and downstream phosphorylation of p-STAT3.
Research Insights
| Supplement | Dose | Health Outcome | Effect Type | Effect Size | Source |
|---|